Quantum BioPharma Ltd C.QNTM

Restore FSD

[Boni94]

And it also includes implementing a strong financial and corporate governance framework so that directors and management are restricted in granting compensation to themselves at levels higher than industry standards.

[Boni94]

There should also have an Implementing audits of prior compensation and expenses incurred by the Company.

[Boni94]

Developing a robust investor relations function to better communicate FSD’s value to the investment community.

[Boni94]

And there is also a press release about Court Orders FSD Pharma to Move Shareholder Meeting Date to May 14, 2021, Imposes Requirement of an Independent Meeting Chair and Prevents Dr. Raza Bokhari and Other Directors from Voting Recently Issued Shares.

[Boni94]

It is also good to know that FSD Shareholders Seek Prompt Shareholder Meeting To Address Ongoing Board and Management Failures so that there will transparency and to continue the company’s operation.

[Boni94]

This earlier meeting date will allow FSD to deal with the issues raised by the Concerned Shareholders while finally satisfying FSD's obligation to hold its long-overdue annual shareholders' meeting – an outcome that is in the best interest of all FSD shareholders.

[junjun26]

That's why Concerned shareholders requested the Court that Dr. Raza Bokhari, the Chair of FSD's board of directors and the Company's Chief Executive Officer, not act as chair of the meeting. Instead, an independent person will be appointed to ensure that the meeting is run in a fair and orderly fashion.

[mhaimillionaire]

In July 2020, the Company established a program for an at-the-market offering of its Class B Shares (the “2020 ATM Offering”) that allowed the Company to sell up to US$20,000,000 Class B Shares on the Nasdaq Capital 11 Market (the “Nasdaq”). Prior to February 1, 2021, FSD had taken virtually no action under the 2020 ATM Offering. However, since the Requisition on January 4, 2021, the Company has